Copyright © Inderes 2011 - present. All rights reserved.
  • Senaste
  • Börs
    • Aktiejämförelse
    • Börskalender
    • Utdelningskalender
    • Aktieanalys
    • Artiklar
  • InderesTV
  • Portfölj
  • Forum
  • Q&A
  • Om oss
    • Bolag under bevakning
    • Teamet
Regulatoriskt pressmeddelande

SensoDetect AB: SensoDetect aims to capture 10% of a €6.8 Billion ASD and ADHD Diagnostics Market

SensoDetect
Läs börsmeddelandet

"We're revolutionizing neurodiagnostics," declares PA Hedin, CEO of SensoDetect AB. "Our breakthrough SensoDetect Diagnostics (SDD) system will transform the current 6-18-month diagnostic process into a 30-minute clinical procedure, including world-first newborn screening capabilities. In a market serving 78 million undiagnosed cases, we're uniquely positioned to drive both clinical impact and strong returns."

Market Opportunity 

- €6.8B global ASD/ADHD diagnostics market 

- 1 in 36 children affected by ASD (CDC 2023) 

- Critical need for early intervention (before age 3) 

Proven Solution 

Objective ABR+AI analysis 

Mass screening capability 

Already deployed in Middle East clinics 

Revenue Drivers 

- Hardware: €2K-€50K/unit 

- Testing: €300/assessment (80% margins) 

- Telemedicine: €200/month subscriptions 

Growth Catalysts 

- 2025: Saudi commercialization 

- 2025: China NMPA approval

- 2026: China commercialization

- 2027: US expansion 

"What sets us apart," continues CEO Hedin, "is our ability to turn this healthcare crisis into a €6.8 Billion market opportunity while delivering life-changing screening and diagnostics. We're not just participating in the neurodiagnostic space - we're redefining it," emphasizes CEO Hedin. "With secured regulatory approvals and clear regulatory pathways, we're targeting 10% market share by 2030." 

Data verified via [CDC](https://www.cdc.gov) | [SEC](https://www.sec.gov) | [SFDA](https://www.sfda.gov.sa)

Följ oss på våra kanaler i social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Ta kontakt
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • Om oss
  • Teamet
  • Jobba hos oss
  • Inderes som en investering
  • Tjänster för börsbolag
Vår plattform
  • FAQ
  • Servicevillkor
  • Integritetspolicy
  • Disclaimer
Inderes disclaimer gällande utförda aktieanalyser kan läsas här. För mer detaljerad information över de aktier som aktivt bevakas av Inderes, vänligen se respektive bolags bolagsspecifika sida på Inderes webbplats. © Inderes Oyj. Alla rättigheter förbehållna.